EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Recent advances and emerging insights in obstructive sleep apnea: implications for diagnosis and cardiovascular risk assessment

Sonia López-Monzoni, Irene Cano-Pumarega, Clementine Puech, Olga Mediano, Manuel Sánchez-de-la-Torre iD

Therapeutic Advances in Respiratory Disease · 2025

DOI: 10.1177/17534666251384397 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2025. Verfasst von Sonia López-Monzoni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Cardiovascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: instituto de salud carlos iii, ministerio de ciencia e innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obstructive sleep apnea (OSA) is a sleep-breathing disorder with repetitive total or partial airway occlusion events. Its importance lies in the high prevalence and presence in all age groups and on cardiovascular (CV), metabolism, neurocognitive function, mental health, and overall quality of life. Furthermore, the coexistence of multiple comorbidities in patients suffering from OSA plays an essential role in these entities’ development, perpetuation, and clinical control. In the past years, efforts have been made to understand the pathophysiology of each event, the spectrum of the disease, and the different phenotypes, as well as to refine the diagnostic process and, thus, direct treatment toward a more comprehensive and personalized approach. Many uncertainties remain regarding which patients are at higher CV risk and who derive the greatest benefit from treatment. In this promising scenario, new tools have been developed, including advanced diagnostic technologies, molecular biomarkers, and predictive statistic models tailored for precision medicine. However, to effectively understand and manage this heterogeneous and complex pathology, well-designed studies are essential to validate precision medicine models and ensure their efficient integration into routine clinical practice in a simple, accessible, and practical manner. In this article, we present a comprehensive review of the most relevant scientific evidence concerning the diagnosis and treatment of OSA. We examine significant cluster studies available to date and aim to provide the reader with personalized recommendations for diagnosing and treating OSA. Additionally, we propose new pathways for advancing precision medicine in the field of sleep-disordered breathing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveCardiovascular DiseasesHumansRisk AssessmentHeart Disease Risk FactorsPrecision MedicineComorbidityQuality of LifePrevalencePrognosis

Stichwörter der Autor:innen

cardiovascular riskhealthy sleeppersonalized medicineprecisionsleep apnea

Autor:innen und Institutionen

  • Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Doctoral School of Universidad de Alcalá de Henares, Universidad de Alcalá, Madrid, Spain.
  • Sleep and Epilepsy Functional Unit, Pneumology Department, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), ISCIII Madrid, Spain.
  • Group of Precision Medicine in Chronic Diseases, Hospital Nacional de Parapléjicos, IDISCAM, Guadalajara, Spain.
  • Department of Nursing, Physiotherapy and Occupational Therapy, Faculty of Physiotherapy and Nursing, University of Castilla-La Mancha, Toledo, Spain.

ORCID-Profile: Manuel Sánchez-de-la-Torre

Förderung

  • instituto de salud carlos iii
  • ministerio de ciencia e innovación

Zitieren

APA

López-Monzoni, S., Cano-Pumarega, I., Puech, C., Mediano, O., & Sánchez-de-la-Torre, M. (2025). Recent advances and emerging insights in obstructive sleep apnea: implications for diagnosis and cardiovascular risk assessment. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666251384397

Vancouver

López-Monzoni S, Cano-Pumarega I, Puech C, Mediano O, Sánchez-de-la-Torre M. Recent advances and emerging insights in obstructive sleep apnea: implications for diagnosis and cardiovascular risk assessment. Therapeutic Advances in Respiratory Disease. 2025. doi:10.1177/17534666251384397

BibTeX
@article{LpezMonzoni2025,
  author = {López-Monzoni, Sonia and Cano-Pumarega, Irene and Puech, Clementine and Mediano, Olga and Sánchez-de-la-Torre, Manuel},
  title = {Recent advances and emerging insights in obstructive sleep apnea: implications for diagnosis and cardiovascular risk assessment},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2025},
  doi = {10.1177/17534666251384397}
}
Kostenlos starten →